Expanding access to nurse-managed medication for opioid use disorder

2021 2015 Andrilla, 2017, Barriers rural physicians face prescribing buprenorphine for opioid use disorder, The Annals of Family Medicine, 15, 359, 10.1370/afm.2099 Andrilla, 2019, Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: A 5-year update, The Journal of Rural Health, 35, 108, 10.1111/jrh.12307 van Boekel, 2016, Inequalities in healthcare provision for individuals with substance use disorders: perspectives from healthcare professionals and clients, Journal of Substance Use, 21, 133 2020 Davis, 2020, Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19, The International Journal on Drug Policy Dugosh, 2016, A systematic review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction, Journal of Addiction Medicine, 10, 91, 10.1097/ADM.0000000000000193 Hedegaard, 2020, Drug overdose in the United States, 1999-2019 Jackson, 2018, Utilization of the nurse practitioner role to combat the opioid crisis, The Journal for Nurse Practitioners, 14, e213, 10.1016/j.nurpra.2018.08.016 Jones, 2015, National and state treatment need and capacity for opioid agonist medication-assisted treatment, American Journal of Public Health, 105, e55, 10.2105/AJPH.2015.302664 Jones, 2019, Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder, Addiction, 114, 471, 10.1111/add.14436 2017 Kleykamp, 2020, Substance use disorders and COVID-19: the role of telehealth in treatment and research, Journal of Social Work Practice in The Addictions, 20, 248, 10.1080/1533256X.2020.1793064 Korthuis, 2017, Primary care–based models for the treatment of opioid use disorder: A scoping review, Annals of Internal Medicine, 166, 268, 10.7326/M16-2149 Lagisetty, 2017, Primary care models for treating opioid use disorders: what actually works? A systematic review, PloS One, 12, 10.1371/journal.pone.0186315 Larochelle, 2018, Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study, Annals of Internal Medicine, 169, 137, 10.7326/M17-3107 Lin, 2019, Comparing buprenorphine-prescribing physicians across nonmetropolitan and metropolitan areas in the United States, The Annals of Family Medicine, 17, 212, 10.1370/afm.2384 Mattick, 2014, Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD002207.pub4 Moore, 2019, Nurse practitioners’ pivotal role in ending the opioid epidemic, The Journal for Nurse Practitioners, 15, 323, 10.1016/j.nurpra.2019.01.005 Moran, 2019 Nielsen, 2016, A synthesis of oral morphine equivalents (OME) for opioid utilisation studies, Pharmacoepidemiology and Drug Safety, 25, 733, 10.1002/pds.3945 2020 Pennsylvania Action Coalition (2019, September 10). Episode 3: The fight for full practice authority in Pennsylvania. Retrieved March 7, 2020, from: https://www.paactioncoalition.org/about/podcast/item/526-episode-3.html Saloner, 2018, Changes in buprenorphine-naloxone and opioid pain reliever prescriptions after the Affordable Care Act Medicaid expansion, JAMA Network Open, 1, 10.1001/jamanetworkopen.2018.1588 Scholl, 2019, Drug and opioid-involved overdose deaths—United States, 2013–2017, Morbidity and Mortality Weekly Report, 67, 1419 Sharma, 2017, Emergency department visits and hospitalizations for the uninsured in Illinois before and after affordable care act insurance expansion, Journal of Community Health, 42, 591, 10.1007/s10900-016-0293-4 2016 2019 2019 2020 Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act or the SUPPORT for Patients and Communities Act H.R. 6, 115th Congress (2018). https://www.congress.gov/bill/115th-congress/house-bill/6 State of Tennessee Public Chapter No. 771. (2020). https://legiscan.com/TN/text/HB1980/2019 2016 Uscher-Pines, 2020, Health center implementation of telemedicine for opioid use disorders: A qualitative assessment of adopters and nonadopters, Journal of Substance Abuse Treatment, 10.1016/j.jsat.2020.108037 Vestal, 2017 Wen, 2017, Impact of Medicaid Expansion on Medicaid-covered utilization of buprenorphine for opioid use disorder treatment, Medical Care, 55, 336, 10.1097/MLR.0000000000000703 Weintraub, 2018, Expanding access to buprenorphine treatment in rural areas with the use of telemedicine, The American Journal on Addictions, 27, 612, 10.1111/ajad.12805 Wilson, 2020, Drug and opioid involved overdose deaths—United States, 2017-2018, Morbidity & Mortality Weekly Report, 69, 290, 10.15585/mmwr.mm6911a4 Wilson-Poe, 2018, The dynamic interaction between pain and opioid misuse, British Journal of Pharmacology, 175, 2770, 10.1111/bph.13873 Woodruff, 2019, Dismantling buprenorphine policy can provide more comprehensive addiction treatment Woolf, 2019, Life expectancy and mortality rates in the United States, 1959-2017, Journal of the American Medical Association, 322, 1996, 10.1001/jama.2019.16932 2018